Provided are methods, test devices, and diagnostic kits for predicting, assessing, and diagnosing the risk of a disease using salivary analysis. The methods comprise providing a whole (unfractionated) saliva sample from a subject; contacting an aliquot of the saliva with two or more lectins under conditions that allow the two or more lectins to bind to a lectin-binding component of the saliva; detecting the amount of bound lectin; and comparing the amount of bound lectin to the amount known to bind a saliva sample from a control patient, to predict the risk of a disease in the subject. Also provided are methods for reducing the risk of a disease and a method for assessing the risk of the disease at a defined level.

 
Web www.patentalert.com

< Cellular targets for treatment of retroviral infection

< Oligonucleotides targeting the UL73 gene region and use thereof

> Methods for cloning amplified nucleic acid molecules

> Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

~ 00613